We are live on ! Find out more
FLNA

Filana Therapeutics
FLNA

107 hedge funds and large institutions have $27.3M invested in Filana Therapeutics in 2025 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 24 increasing their positions, 30 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

47% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 15

28% more call options, than puts

Call options by funds: $2.58M | Put options by funds: $2.02M

4% more funds holding

Funds holding: 103 → 107 (+4)

0.03% more ownership

Funds ownership: 28.52% → 28.55% (+0.03%)

20% less repeat investments, than reductions

Existing positions increased: 24 | Existing positions reduced: 30

32% less capital invested

Capital invested by funds: $40.1M → $27.3M (-$12.8M)

Holders
107
Holders Change
+4
Holders Change %
+3.88%
% of All Funds
1.3%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
22
Increased
24
Reduced
30
Closed
15
Calls
$2.58M
Puts
$2.02M
Net Calls
+$561K
Net Calls Change
-$2.5M

Top Buyers

Rank Fund Capital Flow
1
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$1.5M
2
Jane Street
Jane Street
New York
+$1.02M
3
Point72 Asset Management
Point72 Asset Management
Connecticut
+$959K
4
GCP
GSA Capital Partners
United Kingdom
+$922K
5
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$832K

Top Sellers

Rank Fund Capital Flow
1
JP Morgan Chase
JP Morgan Chase
New York
-$1.81M
2
Goldman Sachs
Goldman Sachs
New York
-$1.41M
3
GC
GMT Capital
Georgia
-$1.31M
4
6CM
683 Capital Management
New York
-$1.24M
5
Morgan Stanley
Morgan Stanley
New York
-$895K
Name Holding Trade Value Shares
Change 		Change in
Stake
MCM
76
MAI Capital Management
Ohio
$2.97K – – –
SAM
77
Smartleaf Asset Management
Massachusetts
$2.78K +$4.38K +1,369 New
SS
78
SBI Securities
Japan
$2.46K -$666 -208 -14%
MB
79
MidFirst Bank
Oklahoma
$1.98K +$3.2K +1,000 New
FHA
80
Flagship Harbor Advisors
Massachusetts
$1.23K +$1.99K +620 New
Carson Wealth (CWM LLC)
81
Carson Wealth (CWM LLC)
Nebraska
$1K -$435 -136 -23%
AAP
82
Arax Advisory Partners
Colorado
$882 – – –
TWC
83
TD Waterhouse Canada
Ontario, Canada
$788 – – –
Jones Financial Companies
84
Jones Financial Companies
Missouri
$782 -$330 -103 -21%
Nisa Investment Advisors
85
Nisa Investment Advisors
Missouri
$717 – – –
SPIA
86
Steward Partners Investment Advisory
New York
$618 – – –
SWP
87
Strategic Wealth Partners
Ohio
$545 – – –
LWMI
88
Legacy Wealth Management (Idaho)
Idaho
$511 – – –
HI
89
Harbour Investments
Wisconsin
$495 – – –
PA
90
Parallel Advisors
California
$483 – – –
SAG
91
SageView Advisory Group
California
$218 +$352 +110 New
FFA
92
Farther Finance Advisors
California
$186 -$3 -1 -1%
SWA
93
SOA Wealth Advisors
New York
$154 – – –
Citigroup
94
Citigroup
New York
$123 -$7.6K -2,374 -97%
HPC
95
HM Payson & Co
Maine
$99 – – –
BAM
96
Byrne Asset Management
New Jersey
$79 – – –
CFD
97
Creative Financial Designs
Indiana
$79 – – –
GSWM
98
Golden State Wealth Management
California
$71 – – –
LWANC
99
Laurel Wealth Advisors (North Carolina)
North Carolina
$34 +$54 +17 New
JP Morgan Chase
100
JP Morgan Chase
New York
$26 -$1.81M -565,426 -100%
1 2 3
4
5

FLNA Hedge Fund Activity: Q4 2025 in Review

107 of the 8,226 institutional investors tracked by Wall St. Rank reported a position in Filana Therapeutics (FLNA) for Q4 2025, worth a combined $27.3M — down 32% from $40.1M a quarter earlier.

Buyers outnumbered sellers: 22 funds opened new FLNA positions and 15 closed out — a net gain of 7 holders — while 24 added to existing stakes and 30 trimmed.

The largest buyer was D.E. Shaw & Co, opening a new position worth an estimated $1.5M. The largest seller was JP Morgan Chase, cutting an estimated $1.81M.

  • 107 institutional investors held Filana Therapeutics (FLNA) as of Q4 2025, up from 103 in Q3 2025.
  • Funds reported $27.3M of Filana Therapeutics stock for Q4 2025, down 32% quarter-over-quarter.
  • 22 funds opened new Filana Therapeutics positions in Q4 2025 and 15 closed out, a net change of +7 holders.
  • The largest Filana Therapeutics buyer in Q4 2025 was D.E. Shaw & Co, an estimated $1.5M added.
  • The largest Filana Therapeutics seller in Q4 2025 was JP Morgan Chase, an estimated $1.81M sold.

Based on aggregated 13F filings for Q4 2025.